Abbott ABT Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 224.6%+2.6pp | 224.1%+2.8pp | 223.1%+2.0pp | 222.8%+2.3pp | 222%+1.6pp | |
| Operating margin | 70.3%+5.0pp | 70%+5.8pp | 68.1%+4.1pp | 66.8%+3.9pp | 65.3%+3.1pp | |
| Net margin | 92.9%+1.5pp | 110.9%+37.4pp | 128.1%+72.3pp | 110.3%+55.5pp | 91.5%+37.5pp | |
| EBITDA margin | 98.7%+2.5pp | 99%+3.3pp | 97.7%+1.7pp | 97%+2.0pp | 96.2%+1.8pp | |
| Free cash flow margin | 64.5%+4.0pp | 63.9%+6.9pp | 62.4%+7.9pp | 62.3%+12.4pp | 60.5%+10.8pp | |
| Returns | ||||||
| Return on equity | 87.4%-3.9pp | 105.8%+30.4pp | 123.8%+64.3pp | 107.9%+49.2pp | 91.3%+33.2pp | |
| Return on assets | 49.7%-0.6pp | 60.7%+20.2pp | 70.3%+39.4pp | 60.6%+30.4pp | 50.3%+20.8pp | |
| Return on invested capital | 49.1%-2.1pp | 54.2%+5.0pp | 56.5%+8.5pp | 53.8%+6.7pp | 51.2%+4.8pp | |
| Efficiency | ||||||
| Asset turnover | 2.1×-0.1× | 2.2×0.0× | 2.2×0.0× | 2.2×0.0× | 2.2×0.0× | |
| Inventory turnover | 11.6×+0.5× | 11.4×+0.4× | 11.3×+0.4× | 11.2×+0.1× | 11.1×-0.1× | |
| Liquidity | ||||||
| Current ratio | 6.5×-0.2× | 6.9×+0.3× | 7×+0.5× | 6.9×+0.2× | 6.7×+0.1× | |
| Quick ratio | 4.7×-0.1× | 5×+0.3× | 5.1×+0.5× | 4.9×+0.3× | 4.8×+0.2× | |
| Cash ratio | 1.9×-0.1× | 2.1×0.0× | 2.1×+0.1× | 2.1×+0.1× | 2.1×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 1.4×+0.1× | 1.1×-0.4× | 1.1×-0.4× | 1.2×-0.3× | 1.3×-0.3× | |
| Debt-to-assets | 0.8×0.0× | 0.6×-0.2× | 0.7×-0.2× | 0.7×-0.1× | 0.8×-0.1× | |
| Net debt / EBITDA | 4.1×+1.2× | 2.3×-0.9× | 2.5×-0.8× | 2.8×-0.8× | 3×-0.7× | |
| Interest coverage | 60×+12.6× | 58.7×+14.1× | 54.5×+12.0× | 50.9×+10.4× | 47.4×+7.5× | |
| Per Share | ||||||
| Book value per share | $117.63+17.1% | $115.77+22.3% | $113.21+26.5% | $106.86+21.2% | $100.43+15.5% | |
| Valuation | ||||||
| Market capitalization | $869.62B+8.0% | $921.28B+19.3% | $899.6B+17.2% | $864.84B+17.3% | $805.37B+8.0% | |
| Enterprise value | $914.4B+9.5% | $945.52B+17.6% | $925.88B+15.7% | $893.12B+15.8% | $834.93B+6.9% | |
| Price / earnings | 95.7×-2.9× | 84.3×-32.3× | 65.5×-69.8× | 83.3×-50.2× | 98.6×-39.1× | |
| Price / sales | 19.8×+0.4× | 21.2×+2.4× | 21×+2.1× | 20.5×+2.2× | 19.4×+0.8× | |
| Price / book | 16.9×-1.5× | 18.2×-0.6× | 18.2×-1.5× | 18.6×-0.5× | 18.4×-1.2× | |
| EV / EBITDA | 84.1×+0.7× | 88.1×+6.3× | 88.4×+6.3× | 87.2×+6.7× | 83.4×+1.0× | |
| EV / sales | 20.8×+0.7× | 21.8×+2.2× | 21.6×+1.9× | 21.2×+2.0× | 20.1×+0.6× | |
| Free cash flow yield | 13.3%+0.8pp | 12.1%-0.1pp | 11.9%+0.4pp | 12.2%+1.3pp | 12.5%+1.8pp | |
| Earnings yield | 18.3%-0.4pp | 20.7%+5.0pp | 24.5%+12.7pp | 21.4%+9.4pp | 18.7%+7.0pp | |
| Dividend yield | 7.6%0.0pp | 7%-0.8pp | 7%-0.6pp | 7.2%-0.6pp | 7.6%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Abbott's profit margins?
- Abbott (ABT) runs a 56.3% gross margin and a 17.1% operating margin, with a 13.9% net margin.
- Where do Abbott's ratios come from?
- Every ratio is computed from Abbott's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
